admin – Hevantra

Uncategorized
admin
December 22, 2025

Cost-Effectiveness Analysis (CEA) in IBD

Objective To assess the cost-effectiveness of treatment strategies in inflammatory bowel disease (IBD), accounting for disease progression and treatment sequencing. Methods Developed a hybrid economic model combining a decision tree with a Markov state-transition framework Modelled key disease states,

Uncategorized
admin
December 18, 2025

Cost-Effectiveness Analysis (CEA) in Oncology

Objective To assess the cost-effectiveness of treatments for locally advanced and metastatic cancer Methods Developed a cohort partitioned survival model informed by published clinical trial data Digitised Kaplan–Meier survival curves to reconstruct patient-level data and fitted appropriate parametric survival

Author: admin

Cost-Effectiveness Analysis (CEA) in IBD

Cost-Effectiveness Analysis (CEA) in Oncology

Ready to navigate your product’s journey to market?

Contact us today to discuss how HEVANTRA can become your partner for HEOR solutions

Quick Links

Service

Contact Info